Shionogi & Co. Ltd.

In News

Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative - Fierce Pharma

Fierce Pharma - Jun 01, 2026

US regulator approves oral drug from Japan's Shionogi to prevent COVID-19 - Reuters

Reuters - Jun 01, 2026

[Press release] Shionogi announces FDA approval of XOCOVA® (ensitrelvir), the first and only oral option to help prevent COVID-19 following exposure - European AIDS Treatment Group

European AIDS Treatment Group - Jun 04, 2026

Biopharma bites: Setbacks for Fulcrum, Praxis, while Shionogi, Moderna make infectious disease strides - FirstWord Pharma

FirstWord Pharma - Jun 01, 2026

Shionogi weighs future of FXS drug after double Phase III miss - Clinical Trials Arena

Clinical Trials Arena - May 14, 2026

Shionogi’s New U.S. And China Drug Approvals Shift Growth Outlook - simplywall.st

simplywall.st - Jun 05, 2026

(ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure - Business Wire

Business Wire - Jun 01, 2026

FDA clears Shionogi’s Xocova as first COVID-19 prevention pill - BioWorld News

BioWorld News - Jun 04, 2026

FDA Approves Oral Ensitrelvir for COVID-19 Postexposure Prophylaxis - AJMC

AJMC - Jun 02, 2026

Shionogi Selected as a “DX Stock 2026”｜塩野義製薬 - Shionogi Inc.

Shionogi Inc. - Apr 10, 2026

Shionogi Secures US Contract to Expand Antibiotic Manufacturing and Biothreat Preparedness - Contagion Live

Contagion Live - Apr 09, 2026

Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats - CIDRAP

CIDRAP - Apr 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment